AzTrials
AzTrials

Kyphosis ThoracicNCT06959680

The Effect of Kinesiotaping on Posture and Balance in Patients With Postural Thoracic Hyperkyphosis

A study testing Exercise and Kinesiotaping and exercise in people with Kyphosis Thoracic and Kyphosis Postural Thoracic, run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary aim of our research is to evaluate the positive effects of exercise and kinesiotaping on the thoracic kyphosis angle in young adults between the ages of 18-45 with a thoracic kyphosis angle of 40 degrees and above. Read more about this study

Who is it for?
Ages 18 to 45 years
What is being tested?
Exercise and Kinesiotaping and exercise
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jun 2025to 1 Jun 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Being between the ages of 18-45
  • Among the patients who applied to the physical medicine and rehabilitation outpatient clinic with poor posture or nonspecific back pain, the kyphosis angle was measured as ≥ 40 on the thoracic lateral radiograph
  • Being literate
  • Agreeing to participate in the research

Who cannot join

  • Patients younger than 18 years and older than 45 years
  • Spinal deformity, Scheuermann disease, disc herniation
  • Previous spine surgery and trauma
  • Neuromuscular, peripheral neuropathic disease
  • Pregnant and postmenopausal women
  • Vertigo disease (central or peripheral cause)
Show all 10Show fewer
  • Use of medication that may cause dizziness (in the last 3 months)
  • Defect of vision
  • Presence of physical deformity or additional disease that will prevent exercise
  • Active skin disease in the area where tape will be applied

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Sultan 2.Abdülhamid Han Training and Research Hospital

    Istanbul, Üsküdar

Other trials in Turkey (Türkiye)

About this study

The primary aim of our research is to evaluate the positive effects of exercise and kinesiotaping on the thoracic kyphosis angle in young adults between the ages of 18-45 with a thoracic kyphosis angle of 40 degrees and above. Secondary aims are to investigate the effects of kinesiotaping on dynamic and static balance, pain, and quality of life in patients with thoracic hyperkyphosis.

Read the detailed description

In young adults, the thoracic kyphosis angle varies between 20-45◦ and 40◦ and above is defined as thoracic hyperkyphosis. The prevalence of thoracic hyperkyphosis is between 20-40% and is most commonly idiopathic . Thoracic hyperkyphosis is associated with back pain, limitation of movement-function, loss of balance, decreased quality of life and increased risk of falls. In the absence of pain or loss of function, especially young patients may present to improve cosmetic appearance. In the first stage of treatment, exercise, manual therapy, and in advanced stages, bracing and surgery can be applied . In treatment to reduce kyphosis, exercise is recommended at all ages and bracing is recommended in selected patients who do not respond to exercise. Multimodal combination therapies have been shown to be effective in young people . Kinesiobanding (KT) is an application that supports fascia, muscles and joints and reduces pain and inflammation . The combination of taping and exercise has been shown to have a positive effect on balance in hyperkyphotic adolescents. There is no study in the literature evaluating the effects of kinesiobanding on both balance parameters and kyphosis angle in young adults with thoracic hyperkyphosis. We think that favorable results can be obtained in the young age group with this study and our study may provide findings that kinesiobanting can be added to exercise therapy in routine treatment.

Sample Size of the Study: The sample size was determined by G-power analysis using the reference article. The number of participants to be included in the study was calculated as 16 patients for each group with G-power with a power of 95% and a type 1 error of 0.05 .

Patients will be randomly allocated to 3 groups. The sample size was calculated using G*Power based on a previous study, with a power of 95% and a type I error rate of 0.05, indicating that 16 patients per group (48 in total) are required. Allowing for an anticipated 20% loss to follow-up, a total of 60 patients (20 per group) will be enrolled in the study.

TREATMENT GROUPS:

Group 1 (E+KT): exercise + kinesio taping Group 2 (E+SH): exercise + sham taping Group 3 (E): exercise

The study groups will be determined according to the eligibility criteria among patients who present to the Physical Medicine and Rehabilitation outpatient clinic with complaints of posture disorder or nonspecific back pain and who have a thoracic kyphosis angle of 40 degrees or more on lateral radiography.

Cobb Angle Measurement:

Thoracic kyphosis angle will be measured on thoracic lateral radiograph. According to the literature, the gold standard measurement method is Cobb angle measurement; since the T4-T12 vertebra angle is less visible above the T4 vertebra level due to the superposition of other structures, the T4-T12 vertebra angle is used. The angle at the intersection point of the lines drawn parallel to the upper endplate of the T4 vertebra and the lower endplate of the T12 vertebra gives the Cobb angle . Patients with a Cobb angle of 40 and above and who do not have any additional disease to explain pain or hyperkyphosis will be included in the study.

Grouping of Participants, Patient Follow-up Form and Evaluations Our study was planned as a randomized single-blind prospective cohort, single-center study. Between 01/06/2025 - 01/06/2026 patients who meet the inclusion criteria among young adults aged 18-45 years who applied to Sultan Abdulhamid Han Training and Research Hospital Physical Medicine and Rehabilitation outpatient clinic with complaints of nonspecific back pain or posture disorder will be included in the study. The study is planned to last 12 months.

Cobb angle measurement on thoracic lateral radiograph, kyphosis angle and index measurement with Flexicurve device, Biodex device, VAS scoring, Berg balance scale, SRS-22 questionnaire, International Physical Activity Questionnaire (Short) (IPAQ) will be used in the study.

Informed consent: After the patients are verbally informed, consent forms will be given to the patients in which the purpose of the study is clearly explained and they will be asked to sign the forms.

Kinesio Taping (1st Group= E+KT Group) Kinesiobant will first be tested on a small area of the forearm and treatment will be discontinued if allergy develops. Taping will be applied with the patient in upright posture and shoulders in retraction. From the level of the acromioclavicular joint, the first 5 cm will be applied without stretching, then maximum stretching will be applied, moving to the diagonal and ending at the lower border of the costa, the adhesion point will be adhered without stretching. The same process will be applied on the opposite side and a total of two I-shaped bands will be used to create an X-shape on the back. The crossing point of the bands will be adjusted to the lower 1/3 of the medial edge of the scapula. Taping will be performed after all initial measurements (T0) and will be renewed weekly (on days 0, 7, 14, 21). At the end of the 1st month, i.e. on day 28 (T1), the last measurements will be made with the kinesio tape and then the tape will be removed. Two months after the end of the treatment, the patient will be called again (T2) and final measurements will be made without the tape.

Sham Taping (2nd group= E+SH group) Sham taping treatment will be performed to exclude the biofeedback effect of taping and to distinguish its functional effect. The patch to be used in sham taping will first be tested on a small area of the forearm and if allergy develops, the treatment will be terminated. Taping will be applied with the patient in upright posture and shoulders in retraction. Skin color, elasticity and non-stretchable plaster of the same color as the skin will be used. From the level of the acromioclavicular joint, it will be applied from the level of the acromioclavicular joint to the diagonal without stretching and will be adhered to the adhesion point without stretching, ending at the lower border of the costa. The same procedure will be applied to the opposite side and an X shape will be formed on the back using a total of two I-shaped plasters. The crossing point of the bands will be adjusted to the lower 1/3 of the medial edge of the scapula. Taping will be performed after all initial measurements (T0) and will be renewed weekly (on days 0, 7, 14, 21). At the end of the 1st month, i.e. on day 28 (T1), the last measurements will be made with the patch and then the tape will be removed. Two months after the end of the treatment, the patient will be called again (T2) and final measurements will be made without the tape.

Exercise Program (3rd group=E group) The exercises were designed as a 4-week home program. In all three groups, the exercises will be performed once a day, 3 days a week, one day apart, for 4 weeks.

Each exercise will be performed with 10 repetitions in the first two weeks and 15 repetitions in the third and fourth weeks, with 5 sec contraction and 5 sec relaxation, with a 1 min break between two different exercises.

In the first phase, patients will be shown exercises to do at home. Afterward, all patients will be given an illustrated exercise brochure and an exercise log; two phone calls per week will be used to encourage patients to adhere to their treatment.

In postural thoracic hyperkyphosis, strengthening, stretching exercises and breathing exercises will be given for the most affected muscle groups. Posture exercises were planned for trapezius, lattismus dorsi, levator scapula, rhomboids, serratus posterior-superior-inferior, longissimus thoracis, spinalis thoracis, iliocostalis thoracis, semispinalis thoracis, multifidus, rotatores thoracis, diaphragm, intercostal externi, abdominal muscles:

  • Thoracic and shoulder girdle strengthening exercises
  • Pelvic and lumbar stabilization exercises
  • Anterior and lateral abdominal muscle strengthening exercises
  • Hip flexor stretching exercises
  • Lumbar extensor stretching exercises
  • Breathing exercises

Kyphosis Angle Measurement with Flexicurve:

At the beginning of the study,at the end of treatment (1st month) and 2 months after the end of treatment (3rd month).The Flexicurve ruler (Staedtler Mars Inc, Nurnberg, Germany),which is a plastic-coated bendable metal band approximately 60 cm long,will be used for the measurements.The ruler bends in only one direction and retains its shape when bent.The patient will stand as upright as possible and the spinous process of the seventh cervical vertebra(C7)and the upper part of the sacrum(S1)will be palpated and marked.The Flexicurve ruler will be placed along the C7-S1 vertebrae to form the shape of the spine,then the ruler will be placed flat on the paper and the lines transferred onto the paper.A vertical line will be drawn to connect the C7 and S1 landmarks.The intersection of this line with the spinal curve previously drawn with the flexicurve ruler will mark the transition between the thoracic and lumbar curves.A straight line drawn between C7 and the intersection point will be recorded as the thoracic kyphosis length (TL) in cm.Thoracic width (TW)will be recorded in cm as the length of the perpendicular line drawn from the apex of the kyphosis to TL.Kyphosis index will be calculated with the formula:(TW/TL) x 100. Each measurement will be performed 3 times by a single assessor, and the mean of the 3 trials will be used for analysis.

Being tested
Exercise and Kinesiotaping, Exercise and Shamtaping, exercise
Keywords
Balance, Postural Kyphosis, Kinesio taping

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise and KinesiotapingOther

    Exercise and Kinesiotaping

  • Exercise and ShamtapingOther

    exercise and sham banding (banding without tension with plaster)

  • exerciseOther

    only exercise will be performed without any band treatment

Study groups in NCT06959680
Study groupRoleWhat they receive
Group 1 Exercise and KinesiotapingExperimentalGroup 1 participants will receive exercise and kinesiotaping treatment
Receives: Other: Exercise and Kinesiotaping
Group 2 Exercise and ShamtapingSham comparatorGroup 2 participants will receive exercise and shamtaping treatment.
Receives: Other: Exercise and Shamtaping
Group 3 ExerciseActive comparatorGroup 3 participants will receive exercise therapy alone
Receives: Other: exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Thoracic hyperkyphosis angle (Kyphosis Angle Measurement with Flexicurve)

    They will be performed at the beginning of the study, at the end of treatment (1st month) and 2 months after the end of treatment (3rd month).

    Kyphosis index will be calculated with the formula: (TW/TL) x 100. Higher indices will indicate higher degrees of kyphosis.

    All measurements will be performed by one specialists, repeated 3 times each and averaged.

    (How to measure is explained in detail in the 'detailed description' section).

    Measured: 12 months

Secondary outcomes (5)
  1. Static and Dynamic Balance Measurement with Biodex Device

    Balance measurement of the patients will be performed with the Biodex Balance System SD (Biodex, Inc, Shirley, NY) (BBS). BBS is a movable circular platform that can move in antero-posterior and medio-lateral axes. In our study; bilateral stance static postural stability test (level 12, stable platform), bilateral stance dynamic fall risk test (level 4, unstable platform), single leg stance postural stability test (stable platform) and stability limit test will be measured. The postural stability measurement includes the overall stability index (OSI), anteroposterior stability index (APSI) and mediolateral stability index (MLSI). High values in these scores indicate poor balance. All balance tests will be performed with eyes open and barefoot and repeated 3 times with a 10-second rest interval.

    Measured: 12 months

  2. Vas (Visual Analog Scale) Scoring

    It will be evaluated before and at the end of treatment and at the end of the 3rd month and the patient will be asked to mark the degree of pain on a linear line with a value between 0-10.

    Measured: 12 months

  3. Berg Balance Scale (Turkish)

    The scale consists of 14 predetermined tasks, each task achievement is scored between 0-4, and will be performed 3 times: before treatment, at the end of the 1st month and at the end of the 3rd month.

    Measured: 12 months

  4. SRS-22 (Turkish)

    The SRS-22 questionnaire, which was developed by the Scoliosis Research Society (SRS) to be used in spinal curvatures and whose Turkish validity and reliability has been proven, will be filled out by patients before, at the end of treatment and at the 3rd month control.

    Measured: 12 months

  5. International Physical Activity Questionnaire (Short) (IPAQ)

    This questionnaire, the Turkish version of which has reliability and validity in assessing physical activity, will be completed by patients before, at the end and at 2 months of treatment to obtain information about their physical activity in daily life.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2025
  2. Study start1 Jun 2025
  3. Primary completion1 Jun 2026
  4. Study completion1 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
There are 3 groups of participants in the study Group 1 participants will receive exercise and kinesiotaping treatment. Group 2 participants will receive exercise and shamtaping treatment. Group 3 participants will receive exercise therapy alone.
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06959680
Sponsor's protocol ID
09.2024.256
Status last verified
Oct 2026
First submitted
28 Apr 2025
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Exercise and Kinesiotaping and exercise in people with Kyphosis Thoracic and Kyphosis Postural Thoracic, run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Thoracic hyperkyphosis angle (Kyphosis Angle Measurement with Flexicurve) (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in